Verdicts
Mar. 31, 2007
Biotech Firms Settle Suit Over Growth Drug
SAN FRANCISCO - A settlement among Genentech, Tercica and Insmed earlier this month resolved the patent infringement litigation among the companies over the right to produce a drug for children who have a severe growth disorder.
Daily Journal Staff Writer
SAN FRANCISCO - A settlement among Genentech, Tercica and Insmed earlier this month resolved the patent infringement litigation among the companies over the right to produce a drug for children who have a severe growth disorder.
The settlement stops Insmed from producing its drug, Iplex, for U.S. patients suffering from growth defects, but it a...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In